Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2942342 | 1.00 | HTT (0.59) | HTTSMN1; SMN2ALDH1A1TAAR1CALM1 | |
| Carbon Monoxide SCHEMBL6904840 | 0.93 | ALDH1A1 (0.54) | HTTSMN1; SMN2ALDH1A1TAAR1CALM1 | |
| SCHEMBL10697363 | 0.89 | CALM1 (0.59) | HTTSMN1; SMN2ALDH1A1TAAR1CALM1 | |
| SCHEMBL12888466 | 0.89 | CALM1 (0.59) | HTTSMN1; SMN2ALDH1A1TAAR1CALM1 | |
| SCHEMBL7277594 | 0.86 | HTT (0.56) | HTTSMN1; SMN2ALDH1A1TAAR1CALM1 | |
| SCHEMBL7604631 | 0.85 | HTT (0.56) | HTTSMN1; SMN2ALDH1A1TAAR1CALM1 | |
| SCHEMBL8338309 | 0.84 | CYP1A2 (0.58) | HTTSMN1; SMN2KDM4EMAPT | |
| SCHEMBL11079473 | 0.84 | CYP1A2 (0.58) | HTTSMN1; SMN2KDM4EMAPT | |
| SCHEMBL879606 | 0.83 | HTT (0.62) | HTTSMN1; SMN2ALDH1A1TAAR1CALM1 | |
| SCHEMBL21592910 | 0.82 | SMN1; SMN2 (0.53) | HTTSMN1; SMN2ALDH1A1TAAR1CALM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116043244-A | Method for preparing alpha, beta-unsaturated ketone by electrocatalytic oxidation of alcohol | 北京化工大学 | 2023-05-02 | — | — | CN | claimed |
| CN-115385805-A | Method for synthesizing dobutamine hydrochloride | 广州仁恒医药科技股份有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-119013316-A | Method for producing polyisobutene succinic anhydride | 巴斯夫欧洲公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-119013315-A | Method for producing polyisobutene succinic anhydride | 巴斯夫欧洲公司 | 2024-11-22 | — | — | CN | disclosed |
| US-20240376245-A1 | COPOLYMERISATION OF ALDEHYDES AND VINYL ETHERS | BASF SE (DE) | 2024-11-14 | — | — | US | disclosed |
| EP-4460492-A1 | COMPOUNDS CONTAINING A HYDROXYPHENYL MOIETY AND THEIR USE | (INSERM) Institut National de la Santé et de la Recherche Médicale (FR) | 2024-11-13 | — | — | EP | disclosed |
| CN-118679194-A | Medium molecular weight polyisobutenes with high content of certain double bond isomers | 巴斯夫欧洲公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-118679193-A | Medium molecular weight polyisobutenes having a particular double bond isomer distribution | 巴斯夫欧洲公司 | 2024-09-20 | — | — | CN | disclosed |
| EP-4406982-A2 | PRODUCTION OF ISOBUTYLENE HOMO- OR COPOLYMER DERIVATIVES | BASF SE (DE) | 2024-07-31 | — | — | EP | disclosed |
| EP-4122971-B1 | COPOLYMERISATION OF ALDEHYDES AND VINYL ETHERS | BASF SE (DE) | 2024-06-19 | — | — | EP | disclosed |
| CN-117751155-A | Copolymerization of aldehydes and vinyl ethers | 巴斯夫欧洲公司 | 2024-03-22 | — | — | CN | disclosed |
| US-20080220487-A1 | Molecular design of thermostable alcohol dehydrogenase for synthesis for chiral aromatic alcohols | THE BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY | 2008-09-11 | — | — | US | disclosed |
| WO-2008013949-A2 | MOLECULAR DESIGN OF THERMOSTABLE ALCOHOL DEHYDROGENASE FOR SYNTHESIS FOR CHIRAL AROMATIC ALCOHOLS | MICHIGAN STATE UNIVERSITY (US) | 2008-01-31 | — | — | WO | disclosed |
| WO-2007102679-A1 | NOVEL THIENOPYRIMIDINE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | JE IL PHARMACEUTICAL CO., LTD. (KR) | 2007-09-13 | — | — | WO | disclosed |
| US-6821783-B1 | FOR PI-ORBITAL CONTAINING SUBSTRATE FOR SUBSEQUENT SYNTHESIS BY COMBINATORIAL CHEMISTRY/MULTIPLE PARALLEL SYNTHESIS (MPS); SOLID PHASE SYNTHESIS | ASTRAZENECA AB (SE) | 2004-11-23 | — | — | US | disclosed |
| EP-1100759-B1 | TRANSITION METAL COMPLEXES AS LINKERS | ASTRAZENECA AB (SE) | 2003-03-26 | — | — | EP | disclosed |
| EP-1100759-A1 | TRANSITION METAL COMPLEXES AS LINKERS | AstraZeneca AB (SE) | 2001-05-23 | — | — | EP | disclosed |
| WO-2000007966-A1 | TRANSITION METAL COMPLEXES AS LINKERS | ASTRAZENECA AB (SE) | 2000-02-17 | — | — | WO | disclosed |
| US-5135955-A | Anticoagulants or antifungal activity | ELI LILLY AND COMPANY (US) | 1992-08-04 | — | — | US | disclosed |
| EP-0339878-A2 | Propanamine derivatives | ELI LILLY AND COMPANY (US) | 1989-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080220487-A1 | Molecular design of thermostable alcohol dehydrogenase for synthesis for chiral aromatic alcohols | ADH5, ADH1C, ADH1A | HTT 2754/4885SMN1; SMN2 3285/4885ALDH1A1 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.